You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 15, October 6, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Urticaria Following Intravenous Doxorubicin Administration

Luis Souhami, Jr, MD; Ronald Feld, MD, FRCP(C)

JAMA. 1978;240(15):1624-1626.


Abstract

Urticaria developed above the site of injection with doxorubicin hydrochloride in 11 patients with malignant neoplasms. Generalized urticaria without anaphylaxis developed in one patient, while only local reactions developed in the other ten. A reaction developed in two patients on their first exposure to doxorubicin. Two of the seven patients who received subsequent doxorubicin therapy had further reactions. Urticaria does not seem to be a contraindication to further treatment with doxorubicin if the patient is closely observed. The value of prophylactic antihistamines or corticosteroids is not clear.

(JAMA 240:1624-1626, 1978)



Author Affiliations

From the Ontario Cancer Institute, University of Toronto, Incorporating the Princess Margaret Hospital, Toronto.


Footnotes

Reprint requests to Ontario Cancer Institute, 500 Sherbourne St, Toronto, Canada M4X 1K9 (Dr Feld).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention and Management of Toxicities Associated With Antineoplastic Drugs
Durivage and Burnham
Journal of Pharmacy Practice 1991;4:27-48.
 

Doxorubicin Hypersensitivity and Clindamycin
Arena and Sherlock
ANN INTERN MED 1990;112:150-150.
ABSTRACT  

Distinctive Eruption Characterized by Linear Supravenous Papules and Erythroderma Following Broxuridine (Bromodeoxyuridine) Therapy and Radiotherapy
Fine and Breathnach
Arch Dermatol 1986;122:199-200.
ABSTRACT  

Combined Modality Treatment of Small Cell Carcinoma of the Lung
Feld et al.
Arch Intern Med 1981;141:469-473.
ABSTRACT  

Hypersensitivity Reactions to Cancer Chemotherapeutic Agents
WEISS and BRUNO
ANN INTERN MED 1981;94:66-72.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.